Pages that link to "Q37224637"
Jump to navigation
Jump to search
The following pages link to Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours (Q37224637):
Displaying 50 items.
- DNA damage-mediated induction of a chemoresistant niche (Q24616267) (← links)
- The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined (Q26748848) (← links)
- IL-6 pathway in the liver: From physiopathology to therapy (Q26766606) (← links)
- The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation (Q26778930) (← links)
- Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development (Q26851211) (← links)
- SOCS, inflammation, and cancer (Q26991808) (← links)
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling (Q27002391) (← links)
- Molecular pathogenesis of hepatic adenomas and its implications for surgical management (Q27027370) (← links)
- β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis (Q28087660) (← links)
- Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer (Q28267996) (← links)
- Inflammation- and stress-related signaling pathways in hepatocarcinogenesis (Q28387669) (← links)
- Inflammation and skeletal metastasis (Q28396089) (← links)
- Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo (Q28472494) (← links)
- A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis (Q28818626) (← links)
- Stat3 is a candidate epigenetic biomarker of perinatal Bisphenol A exposure associated with murine hepatic tumors with implications for human health (Q28834275) (← links)
- STATs in cancer inflammation and immunity: a leading role for STAT3 (Q29547203) (← links)
- Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression (Q29615766) (← links)
- Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity (Q30460181) (← links)
- Intracellular signaling prevents effective blockade of oncogenic gp130 mutants by neutralizing antibodies (Q33557104) (← links)
- IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis (Q33561833) (← links)
- Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation (Q33737707) (← links)
- Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling (Q33779633) (← links)
- Next-generation genomic profiling of hepatocellular adenomas: a new era of individualized patient care. (Q33833379) (← links)
- Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy (Q33866426) (← links)
- Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling? (Q33921803) (← links)
- Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage (Q33930343) (← links)
- Role of Wnt/β-catenin signaling in liver metabolism and cancer (Q33940403) (← links)
- Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data (Q33951424) (← links)
- Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors (Q33959754) (← links)
- SAMD9L inactivation promotes cell proliferation via facilitating G1-S transition in hepatitis B virus-associated hepatocellular carcinoma (Q33970149) (← links)
- Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. (Q33979918) (← links)
- HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines (Q34040991) (← links)
- Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells (Q34056571) (← links)
- Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes (Q34078669) (← links)
- STAT3 activation in monocytes accelerates liver cancer progression (Q34089708) (← links)
- Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse (Q34185231) (← links)
- JAKs and STATs in immunity, immunodeficiency, and cancer (Q34321767) (← links)
- gp130 at the nexus of inflammation, autoimmunity, and cancer (Q34378756) (← links)
- LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease (Q34434347) (← links)
- A gp130-Src-YAP module links inflammation to epithelial regeneration (Q34465259) (← links)
- HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes (Q34651638) (← links)
- MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. (Q34934907) (← links)
- STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. (Q34936215) (← links)
- Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target (Q34940989) (← links)
- Molecular pathology of hepatic neoplasms: classification and clinical significance (Q34954493) (← links)
- Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer (Q34972461) (← links)
- A dual role for the immune response in a mouse model of inflammation-associated lung cancer (Q35015686) (← links)
- Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? (Q35048768) (← links)
- IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii (Q35058854) (← links)
- Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma (Q35064011) (← links)